» Articles » PMID: 23002382

Optimal Warfarin Management for the Prevention of Thromboembolic Events in Patients with Atrial Fibrillation: a Systematic Review of the Clinical Evidence

Overview
Date 2012 Sep 25
PMID 23002382
Affiliations
Soon will be listed here.
References
1.
Savelieva I, Bajpai A, Camm A . Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Ann Med. 2007; 39(5):371-91. DOI: 10.1080/07853890701320662. View

2.
Menke J, Luthje L, Kastrup A, Larsen J . Thromboembolism in atrial fibrillation. Am J Cardiol. 2010; 105(4):502-10. DOI: 10.1016/j.amjcard.2009.10.018. View

3.
Ogilvie I, Newton N, Welner S, Cowell W, Lip G . Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010; 123(7):638-645.e4. DOI: 10.1016/j.amjmed.2009.11.025. View

4.
Marinigh R, Lip G, Fiotti N, Giansante C, Lane D . Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol. 2010; 56(11):827-37. DOI: 10.1016/j.jacc.2010.05.028. View

5.
Hankey G . Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?. Curr Opin Neurol. 2009; 23(1):65-72. DOI: 10.1097/WCO.0b013e328334e67b. View